Air Products Foundation Makes $100,000 Grant to Assist Novel Coronavirus Recovery Efforts in China

▴ Air Products Foundation Makes $100,000 Grant to Assist Novel Coronavirus Recovery Efforts in China
Foundation Grant Builds on Earlier Donation from Air Products China to Support Local Relief Efforts

Air Products (NYSE: APD) today announced that the Air Products Foundation has awarded a $100,000 grant, approximately 700,000 renminbi, to assist novel coronavirus (COVID-19) recovery efforts in China.

"As the world navigates the challenges and threats from COVID-19, I want to express my full support—and the support and solidarity of all of Air Products—as many dedicated organizations and individuals continue their important work," said Seifi Ghasemi, chairman, president and chief executive officer at Air Products. "I am very proud of our teams in China, across Asia and around the world who have been working hand in hand and supporting each other with one common goal: keeping our employees safe and continuing to support our customers, operations and local communities."

Air Products has almost 4,000 employees in China, but none based in Wuhan, the epicenter of the outbreak.

The Air Products Foundation grant builds on other company efforts, including an earlier donation of 500,000 renminbi, approximately $70,000, from Air Products China to the Red Cross in China to support the most urgent medical care needs. In addition, Air Products has continued to deliver needed medical liquid oxygen and helium to hospitals in the Hubei province and across China.

Tags : #AirProducts #100000grant

About the Author


Team Medicircle

Related Stories

15 Oct

Rentschler Biopharma collaborates with ATUM

Rentschler Biopharma and ATUM announce leap-In Transposase licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

View
15 Oct

Celltrion Launches CT-P59, an antibody preventive treatment for COVID-19

Celltrion launches post-exposure prophylaxis clinical trial of anti-COVID-19 monoclonal antibody treatment candidate, CT-P59

View
15 Oct

Dyno Therapeutics deal with Roche has potential for $1.8 billion in revenue

This new partnership represents Dyno’s largest collaboration to date and this will expand the frontier of gene therapies for the central nervous system and liver

View
15 Oct

Roche intends to launch SARS-CoV-2 antigen test in suspected COVID-patients

These fully automated systems can provide test results in 18 minutes for a single test, excluding time for sample collection, transport, and preparation

View
15 Oct

Merck’s New VirusExpress Platform Speeds Development of Cell and Gene Therapies

Cell and gene therapies offer the potential for curative treatments and are being developed and commercialized in half the time it has taken traditional therapies

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025